High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Scand J Clin Lab Invest 71(1):52-62 (2011) PMID 21108561
Patients with stable coronary artery disease (CAD) have a poor prognosis. The aim of the study was to evaluate the extent to which serum high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) measurement alone or together could be prognostic biomarkers in patients with stable CAD.
DOI: 10.3109/00365513.2010.538081
Version: za2963e q8zae q8zb4 q8zc0 q8zdf q8ze5 q8zfc q8zg4